We're pleased to announce that Praxis Genomics has been officially listed as a service provider for Complete Genomics, joining an elite network of laboratories equipped with state-of-the-art sequencing technology for clinical and research applications.
About Complete Genomics
Complete Genomics, a subsidiary of MGI Tech, is a global leader in genomic sequencing technology. Their platforms are renowned for:
- Ultra-high accuracy sequencing with unique DNB (DNA Nanoball) technology
- Cost-effective whole genome sequencing at scale
- Robust performance across diverse sample types and applications
- Industry-leading data quality and reproducibility
What This Means for Our Clients
This partnership enhances our already comprehensive testing capabilities by:
Expanded Sequencing Capacity
Access to Complete Genomics platforms allows us to process larger volumes of samples without compromising quality or turnaround time, ensuring we can meet growing demand for comprehensive genomic testing.
Enhanced Data Quality
Complete Genomics' unique sequencing technology provides exceptional accuracy, particularly important for detecting low-frequency variants in cancer diagnostics and identifying subtle genomic changes in constitutional disorders.
Comprehensive Coverage
The platform's performance characteristics make it ideal for whole genome sequencing applications where comprehensive, uniform coverage is essential for accurate variant detection.
Integration with Our Multi-Platform Approach
Complete Genomics sequencing complements our existing technology suite:
- Short-Read WGS: Complete Genomics platforms provide high-accuracy base-level variant detection
- Long-Read Sequencing: PacBio and Oxford Nanopore technologies resolve complex structural variants and repetitive regions
- Optical Genome Mapping: Bionano Saphyr detects large structural variants and provides genome-wide context
- Transcriptome Analysis: RNA sequencing validates functional impact and reveals expression changes
Commitment to Technological Excellence
Our investment in diverse sequencing platforms reflects our commitment to providing the most comprehensive genetic testing available. No single technology can detect all types of genetic variation—by integrating multiple complementary approaches, we maximize diagnostic success rates for our clients.
Clinical Applications
Complete Genomics technology enhances our capabilities across multiple testing categories:
- Constitutional Disorders: Comprehensive whole genome analysis for rare disease diagnosis
- Cancer Genomics: Tumor-normal comparisons with high sensitivity for somatic variants
- Prenatal Testing: Rapid, accurate aneuploidy detection and comprehensive fetal genome analysis
- Carrier Screening: Precise identification of pathogenic variants for family planning
Looking Forward
This partnership with Complete Genomics represents another step in our mission to provide best-in-class genomic diagnostics. As sequencing technologies continue to advance, we remain committed to evaluating and implementing innovations that benefit our clients and the patients they serve.
Learn more: Complete Genomics Service Providers
Interested in our comprehensive genomic testing services? Explore our test menu or contact our team.
